Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-1-20
pubmed:abstractText
With the success of Phosphodiesterase (PDE) type 5 inhibitors (i.e., sildenafil, tadalafil, vardenafil) in the treatment of erectile dysfunction (ED), PDEs are considered attractive targets for drug intervention in the urogenital tract.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/3',5'-Cyclic-GMP Phosphodiesterases, http://linkedlifedata.com/resource/pubmed/chemical/Carbolines, http://linkedlifedata.com/resource/pubmed/chemical/Cyclic Nucleotide..., http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/PDE5A protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Phosphodiesterase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Phosphoric Diester Hydrolases, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Purines, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Sulfones, http://linkedlifedata.com/resource/pubmed/chemical/Triazines, http://linkedlifedata.com/resource/pubmed/chemical/sildenafil, http://linkedlifedata.com/resource/pubmed/chemical/tadalafil, http://linkedlifedata.com/resource/pubmed/chemical/vardenafil
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1743-6095
pubmed:author
pubmed:issnType
Print
pubmed:volume
1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
322-36
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:16422964-3',5'-Cyclic-GMP Phosphodiesterases, pubmed-meshheading:16422964-Animals, pubmed-meshheading:16422964-Carbolines, pubmed-meshheading:16422964-Cyclic Nucleotide Phosphodiesterases, Type 5, pubmed-meshheading:16422964-Ejaculation, pubmed-meshheading:16422964-Erectile Dysfunction, pubmed-meshheading:16422964-Humans, pubmed-meshheading:16422964-Imidazoles, pubmed-meshheading:16422964-Male, pubmed-meshheading:16422964-Phosphodiesterase Inhibitors, pubmed-meshheading:16422964-Phosphoric Diester Hydrolases, pubmed-meshheading:16422964-Piperazines, pubmed-meshheading:16422964-Purines, pubmed-meshheading:16422964-RNA, Messenger, pubmed-meshheading:16422964-Sulfones, pubmed-meshheading:16422964-Time Factors, pubmed-meshheading:16422964-Triazines, pubmed-meshheading:16422964-Urogenital System
pubmed:year
2004
pubmed:articleTitle
Review of phosphodiesterases in the urogenital system: new directions for therapeutic intervention.
pubmed:affiliation
Department of Urology, Università Vita Salute San Raffaele, Milan, Italy. francesco.montorsi@hsr.it
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural